A new study discovered a previously unknown mechanism by which dopamine drives mitochondrial energy production.
Northwestern Medicine scientists have discovered that mutations in the largest genetic contributor to ALS leads to the dysfunction and eventual degeneration of certain specialized subtypes in the brain. The findings may lead to development of novel therapeutic interventions for the disease.
Northwestern has formed the Center for Translational Pain Research, which aims to advance basic and clinical science in the hopes of developing non-addictive treatments for chronic pain.
Joel Voss, PhD, and John Disterhoft, PhD, have received a $6.3 million grant from the NIH as part of the BRAIN Initiative.
Talia Lerner, PhD, has received the NIH Director’s New Innovator Award, an early-career grant supporting projects in the biomedical, behavioral or social sciences.
A molecule drastically reduced toxic proteins in human neuron cells with Huntington’s disease, representing a potential therapy for the deadly degenerative disease, according to a new study.
Northwestern Medicine scientists have discovered that the protein FMRP — the loss of which leads to Fragile X syndrome — is a novel reader of RNA methylation.
A new study published in Developmental Cell discovered a link between a previously unknown mitochondrial process and Charcot-Marie-Tooth disease Type 2, a genetic neuropathy.
With advances in technology and genetics, Feinberg and Northwestern investigators are conducting basic science research to understand just how the retina works in concert with the brain.